A new-generation clinical trial for glioblastoma multiforme (GBM) — the deadliest form of brain cancer – will begin enrolling patients by mid-year 2016. The trial is designed to identify effective treatments faster for this aggressive form of brain cancer which kills half of all patients diagnosed within one year. Five years after diagnosis, the survival rate is less than 2 percent.
国际审判是自适应的，意思是...
An MD Anderson study may explain why chemotherapy drugs such as gemcitabine are ineffective against pancreatic cancer in some patients. The...
A team led by researchers at MD Anderson Cancer Center reports a crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system. The study was published in the Journal of the National Cancer Institute.
“Identifying this role for tumor-suppressing p53 provides both a potential biomarker for response to important new cancer immunotherapy...
西妥昔单抗，市售为Erbitux®å，是用于治疗转移性结肠直肠癌的关键疗法之一。然而，癌症仍然会返回一些患者...
饮食s high in meats cooked by high-temperature techniques such as barbecuing and pan-frying, which produce carcinogenic compounds, may lead...
凭借最新进展外囊泡的生物以及它们在细胞间通讯的作用，Codiak生物科技公司，公司...
MD安德森癌症中心was awarded more than $22 million in research grants in November from the Cancer Prevention and Research Institute...
